+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Deferiprone (CAS 30652-11-0) Global Market Research Report 2024

  • PDF Icon

    Report

  • 50 Pages
  • December 2024
  • Region: Global
  • Merchant Research and Consulting Ltd
  • ID: 4171226
Description Jump to:
This global report is a result of industry experts’ diligent work on researching the world market of Deferiprone. The report helps to build up a clear view of the market trends and developments, identify major players in the industry, and estimate main downstream sectors.

The Deferiprone global market report's key points:

  • Deferiprone description, applications and related patterns
  • Deferiprone market situation
  • Deferiprone manufacturers and distributors
  • Deferiprone prices
  • Deferiprone end-users
  • Deferiprone downstream industries trends
The first chapter introduces the product (composition, structure, hazards, storage, toxicological & ecological information, etc.).

The second chapter focuses on Deferiprone end-uses. The third chapter summarizes data about manufacturing methods.

The fourth chapter is about the related patents. The fifth chapter deals with Deferiprone market trends and forecast, distinguish Deferiprone manufacturers and suppliers.

The sixth chapter provides Deferiprone prices data.

The seventh chapter analyses Deferiprone downstream markets.


This product will be delivered within 5-7 business days.

Table of Contents

1. DEFERIPRONE GENERAL INFORMATION
1.1. General information, synonyms
1.2. Composition, chemical structure
1.3. Safety information
1.4. Hazards identification
1.5. Handling and storage
1.6. Toxicological & ecological information
1.7. Transport information

2. DEFERIPRONE APPLICATIONS

3. DEFERIPRONE MANUFACTURING METHODS

4. DEFERIPRONE PATENTS

5. DEFERIPRONE MARKET WORLDWIDE
5.1. Global Deferiprone market analysis: market constraints, drivers and opportunities
5.2. Manufacturers of Deferiprone
  • Europe
  • Asia
  • North America
  • Etc.
5.3. Suppliers of Deferiprone
  • Europe
  • Asia
  • North America
  • Etc.
5.4. Market forecast

6. DEFERIPRONE MARKET PRICES
  • Europe
  • Asia
  • North America
7. DEFERIPRONE END-USE SECTOR

Related Topics

Related Reports

Deferiprone Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Image

Deferiprone Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 69 Pages
  • Global
From
Deferiprone Market By Form: Global Opportunity Analysis and Industry Forecast, 2024-2033 - Product Image

Deferiprone Market By Form: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • Report
  • 280 Pages
  • Global
From
Thalassemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Thalassemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 130 Pages
  • Global
From
Iron Overload Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Iron Overload Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 138 Pages
  • Global
From
Hemochromatosis (Iron Overload) Disease Treatment Global Market Report 2024 - Product Image

Hemochromatosis (Iron Overload) Disease Treatment Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From

About the Deferiprone Market

Deferiprone is a hematological drug used to treat iron overload in patients with thalassemia, a genetic blood disorder. It is an oral chelator, meaning it binds to iron in the body and helps to remove it from the bloodstream. Deferiprone works by reducing the amount of iron in the body, which can help to reduce the symptoms of thalassemia. It is also used to treat other conditions such as sickle cell anemia, myelodysplastic syndrome, and aplastic anemia. Deferiprone is available in both generic and brand-name forms. It is typically taken three times a day, with or without food. Common side effects include nausea, vomiting, and diarrhea. More serious side effects may include liver damage, anemia, and low white blood cell count. The deferiprone market is highly competitive, with several companies offering their own versions of the drug. Some of the major players in the market include Novartis, Sanofi, and Teva Pharmaceuticals. Other companies include Actavis, Apotex, and Mylan. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.